Cinzia Iotti
Overview
Explore the profile of Cinzia Iotti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
447
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Iori F, Augugliaro M, Ali E, Iotti C
Clin Transl Radiat Oncol
. 2025 Jan;
51():100909.
PMID: 39845564
The role of elective pelvic nodal irradiation (EPNI) for high-risk prostate cancer (hrPC) management is still an open issue, especially for the elderly patients. It is unclear whether older patients...
2.
Iori F, Trojani V, Zamagni A, Ciammella P, Iori M, Botti A, et al.
Adv Radiat Oncol
. 2024 Dec;
10(1):101665.
PMID: 39687474
Purpose: Spatially fractionated radiation therapy (SFRT) is an irradiation technique developed to improve large cancer response. Although preliminary studies report highly positive results, data are still limited. The aim of...
3.
Botti A, Finocchiaro D, Panico N, Trojani V, Paolani G, Iori F, et al.
Phys Med
. 2024 Sep;
126:104823.
PMID: 39332099
Purpose: Lattice radiotherapy (LRT) is a three dimensional (3D) implementation of spatially fractionated radiation therapy, based on regular spatial distribution of high dose spheres (vertices) inside the target. Due to...
4.
Jahanbakhshi A, Najafi M, Gomar M, Ciammella P, Ruggieri M, Iotti C, et al.
J Pers Med
. 2024 Aug;
14(8).
PMID: 39201994
Background: Meningiomas are the most prevalent benign intracranial tumors. When they are of the invasive subtypes, i.e., grades II and III, they can recur rapidly and present a real challenge...
5.
Mangone L, Marinelli F, Bisceglia I, Filice A, Braghiroli M, Roncaglia F, et al.
Biology (Basel)
. 2024 Jul;
13(7).
PMID: 39056693
The COVID-19 pandemic has caused delays in cancer diagnoses and reductions in treatments. The aim of this work is to evaluate the impact of the pandemic on prostate cancer by...
6.
Guberti M, Schiroli D, Marraccini C, Mazza G, Iotti C, Baricchi R, et al.
Medicine (Baltimore)
. 2023 Sep;
102(34):e34779.
PMID: 37653754
Introduction: Acute radiodermatitis is a significant complication of cancer radiotherapy, and platelet-based therapies are emerging as potential new treatments. Main Symptoms And Important Clinical Findings: In this report, we present...
7.
Cozzi S, Ruggieri M, Bardoscia L, Najafi M, Blandino G, Giaccherini L, et al.
J Cancer Res Ther
. 2023 Jul;
19(3):644-649.
PMID: 37470588
Background: After coronavirus disease outbreak emerged in 2019, radiotherapy departments had to adapt quickly their health system and establish new organizations and priorities. The purpose of this work is to...
8.
Cozzi S, Ruggieri M, Ali E, Finocchi Ghersi S, Vigo F, Augugliaro M, et al.
In Vivo
. 2023 Mar;
37(2):777-785.
PMID: 36881094
Background/aim: Radiotherapy represents an important therapeutic option in the management of prostate cancer (PCa). As helical tomotherapy may improve toxicity outcomes, we aimed to evaluate and report the toxicity and...
9.
Grehn M, Mandija S, Miszczyk M, Krug D, Tomasik B, Stickney K, et al.
Europace
. 2023 Mar;
25(4):1284-1295.
PMID: 36879464
The EU Horizon 2020 Framework-funded Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary (STOPSTORM) consortium has been established as a large research network for...
10.
Najafi M, Jahanbakhshi A, Finocchi Ghersi S, Giaccherini L, Botti A, Cavallieri F, et al.
Brain Sci
. 2023 Feb;
13(2).
PMID: 36831702
The most prevalent and deadly primary malignant glioma in adults is glioblastoma (GBM), which has a median survival time of about 15 months. Despite the standard of care for glioblastoma,...